Difference between revisions of "Team:Toulouse France/Design"

Paleotilis project

Developing a biological solution to protect one of the most invaluable humanity heritage is a beautiful challenge. But using a GMO in an unstable ecosystem is a very risky business. For these reasons, our project has been carefully designed from intense discussions with scientists, curators and the public. It was mandatory to ensure the best confinement strategy for our strain, to limit the material input in the cave and to ensure antifungal production only when required. These lead us to divide our project in three modules (Containment, Predation, Antifungal; Figure 1).

Figure 1: Bacillus subtilis transformed with the two plasmids carrying the elements necessary to promote predation, to prevent the plasmid dissemination, and to produce antifungals molecules.

Predation

Context:

The Lascaux history has proved that any molecule addition could result in major and unexpected modifications of the cave microbiota. For example, the antifungal molecules abundantly used to fight against fungi infection have been degraded by Pseudomonas fluorescens, and this degraded molecules are used by fungi to proliferate… A major constraint we imposed to our project was thus to avoid adding nutriment in the cave.

Our solution:

We circumvented this difficulty by taking advantage of the predatory property of Bacillus subtilis: in starvation condition, one program of Bacillus is to produce toxins to kill other bacteria such as Pseudomonas species and to develop from their materials (Nandy et al, 2007). This has two valuable advantages: (i) no substrate are required when using the bacteria, and (ii) our Bacillus will reduce the deleterious population of Pseudomonas fluorescens (Martin-Sanchez et al, 2011). Besides, Bacillus species are inhabitants of the cave (Martin-Sanchez et al, 2014) and Bacillus subtilis is a model microorganisms with well-established genetic possibilities, i.e, the perfect chassis for our project (Figure 2).

Figure 2: In the cave, Pseudomonas species degrade the antifungal molecules previously used to prevent mould apparition. The degraded molecules are paradoxically used by fungal species to develop. Our Bacillus strain will develop from Pseudomonas, and in contact to fungi, will produce antifungal molecules to prevent mould development.

Our constructions:

Two independent operons have been reported to allow for the predation property of Bacillus subtilis: the sporulation killing factor (skf) and the sporulation delay protein (sdp) (Gonzalez-Pastor et al, 2003; Ellermeier et al, 2006; Gonzalez-Pastor, 2011). We tried both of them for this project. Since their expression is regulated at the transcriptional level, we decided to replace their promoter by pVeg for a constitutive expression (Figure 3). RFP expression was also added in prevision of a visualisation of the strain during test on stones.

Figure 3: Predation constructions. SDP is composed of two operons (sdpABC and sdpIR) while SKF is a big operon (skfABCEFGH) of about 6 Kbp. These sequences encodes the necessary elements to produce, mature and secrete the killing factors, as well as the immunity agents to prevent lethality of the producing cells.

Antifungals

Context:

The Paleotilis project main idea is to contain the fungi patch progression in the Lascaux cave. Since treating with antifungal molecules has proved to be at the best a limited option, we wonder about how to produce antifungal in a targeted and efficient way.

Our solution:

Since a variety of mould has been identified to cause problem in the cave, we wanted a wide spectrum solution and decided for an antifungal cocktail. 5 different molecules were selected:

- D4E1, a 17 amino acids synthetic peptide analog to Cecropin B AMPs which has been shown to have antifungal activities by complexing with a sterol present in the conidia’s wall of numerous fungi (De Lucca et al, 1998).

- Dermaseptin-b1, a 78 amino acids peptide from Phyllomedusa bicolor which has antifungal activities against filamentus fungus. This peptide is membranotropic and depolarizes the fungi plasma membrane (Fleury et al, 1998).

- GAFP-1 (Gastrodia Anti Fungal Protein 1), a mannose and chitin binding lectin originating from the Asiatic orchid Gastrodia elata, that inhibits the growth of ascomycete and basidiomycete fungal plant pathogens (Wang et al, 2001).

- Metchnikowin, a 26 residus prolin-rich peptid from Drosophilia melanogaster with a broad antifungal spectrum against Ascomycete and Basidiomycete. During its expression, it is cleaved in the endoplasmic reticulum. As we did not know if this cleavage is essential for the antifungal activity, we choose to use either the cut or entire form of this peptide (Levashina et al, 1995).

Besides, we wanted to express these peptides only in close vicinity of the fungi. We therefore investigated the possibility to use Bacillus promoters induced by N-Acetyl-Glucosamine (NAG). This molecule is the major component of chitin found at the surface of the fungi.

Our constructions:

To simplify the cloning, we designed two genetics modules: Antifungal A and Antifungal B. Antifungal A expresses the cut Metchnikowin and D4E1, while Antifungal B produces entire Metchnikowin, GAFP-1 and Dermaseptin-b1 (figure 6). These two parts were designed to be easily unified as one 5 ORFs operon. For the secretion of these antifungal compounds, we added the AmyE signal peptide in N-terminal of each coding sequences. This peptide is cleaved during the secretion process. The pVeg promoter was used to express the construction during the validation assays. NheI, SacII and SalI restrictions sites were added to further facilitate the modules assembly.

To express the antifungal peptides only in presence of the fungi, we selected the Bacillus promoter of nagA and nagP, reported to be induced in presence of NAG (Bertram et al., 2011). To valid the expression and specificity of these promoters, the RFP reporter gene has been placed under their control (Figure 7). NheI restrictions sites were added to further facilitate the modules assembly.

Figure 6: Antifungal operons design and assembly

Confinement

Context:

Our project involved release of a genetically modified bacteria in the cave. Lascaux cave is not a completely closed system; there is interaction with external environment due to water infiltration. The risk to release a GMO in the cave is mainly in the horizontal gene transfer to native bacteria.

Our solution:

We decided for a double toxin-antitoxin system (Figure 4). The idea is to prevent plasmid transfer by having two plasmids that have to remain together or cause lethality. One plasmid contains antitoxin 1 and toxin 2, the other contains antitoxin 2 and toxin 1.

Figure 4: concept of the double toxin/antitoxin system.

Our constructions:

The two pairs of Toxin-Antitoxin combinations selected for this project are MazF/MazE (Bravo et al., 1987, Zhang et al., 2005, Wang et al., 2013) and Zeta/Epsilon (Zielenkiewicz and Cegłowski, 2005 ; Mutschler et al., 2011). The toxin and antitoxin are under control of the pVeg constitutive promoter for Bacillus subtilis (BBa_K143012; Figure 5).

Since each fragment contains a toxin but not its corresponding antitoxin, we needed a strategy to avoid cell death during the cloning steps. We chose to use an unusual theophylline sensitive riboswitch to shutdown expression of the toxin when required: In the absence of the ligand, the RBS sequence is available and RNA translation is possible. In ligand presence, RNA shape changes and RBS is no more accessible (Figure 5). It is unusual in the sense theophylline riboswitches usually work in the inverse way (Topp and Gallivan, 2008). The SacII and SalI restriction sites were added to simplify the modules assembly.

Figure 5: toxin/antitoxin constructions for each plasmid

Device

Our whole project rests on the bacteria, which is programmed to cure the cave. However, the bacteria was genetically modified, and thus it is important to ensure the bacteria confinement. Indeed, the bacteria must not be released in the environment to avoid the natural ecosystem’s disruption.

The conception of the device has not for sole objective to confine Bacillus subtilis, because it has also the advantage to ease the application of bacteria on the walls.

Throughout its modern design, our device is quite easy to use and gathers several functions. First of all, let’s talk about its aspect. The device is a double hollow half spheres of X and Y cm of diameter, and separated by a layer of air. The spheres are in a hard transparent material, and the base of it is made in a flexible material, able to match the reliefs of the cave’s wall.

The device is portative and has to be placed against the wall thanks to two handles. As soon as it is positioned on the stains caused by microorganisms, it is necessary to push a button and the vacuum will be done between the two half spheres. Thus the device will be maintained against the wall because of the negative pressure.

Now that the device is placed, our super bacteria can come into play. Another button activates the pulverisation of bacteria in a liquid medium, from the top of the smallest half sphere to the rocky wall. At the contact of fungi and colored bacteria, our modified Bacillus subtilis will use these microorganisms to grow and reduce their population. When they will disappear, the colored stains should also be vanished. Thus, our bacteria will not have enough nutrients to grow, and thus will be naturally eliminated. Finally, the device can be taken off from the wall by reintroducing air between the two half spheres.

Following the development of our B. subtilis is important to determine when the device can be removed. As a consequence, UV lights are fixed in the apparatus, and highlight the natural fluorescence of Bacillus subtilis.

Assembly

All the parts from the three modules were designed to be easily assembled (figure 8). The EcoRI/NheI fragment containing a pNag promoter (figure 7) will have to be swapped with the EcorI/NheI fragment containing the pVeg promoter of the antifungal operon (figure 6). We also designed the toxin/antitoxin systems in a way that one of the toxin gene could be inserted in the middle of the antifungal operon (SacII/SalI insertion, figure 8). The rationale for this was to have the toxin as close as possible to the antifungal molecule to further reduce the risk of antifungal gene horizontal transfer.

Figure 8: final assembly of the parts

Finally, if we decided to use the common Bacillus subtilis 168 strain for the modules validation, the final chassis was choosen to be a double mutant Spo0A- recA-. Indeed, lot of sequences are repeated on our plasmids (pVeg, RBS, terminators and backbone for instance). One possibility was to modify the sequences to reduce the homologies intra and between plasmids, or to find other elements and backbones, but it appears to be too complicated in a short delay. We therefore opted for a recA- strain to reduce the recombination capacity of Bacillus. Besides, we do not want our strain to be able of sporulation since this could jeopardize our capacity to neutralize the strain, hence the choice of a Spo0A mutation.

And now, it is time for results!

Cloning Approach

We synthesized our constructions thanks to IDT gblock.
These conditions allow us to transform our bacteria with a single plasmid in a media containing 1mM Theophylline.

Strategie globale de clonage Spo0A